NO308396B1 - FremgangsmÕte ved fremstilling av substanser av polypeptidnatur - Google Patents

FremgangsmÕte ved fremstilling av substanser av polypeptidnatur

Info

Publication number
NO308396B1
NO308396B1 NO932101A NO932101A NO308396B1 NO 308396 B1 NO308396 B1 NO 308396B1 NO 932101 A NO932101 A NO 932101A NO 932101 A NO932101 A NO 932101A NO 308396 B1 NO308396 B1 NO 308396B1
Authority
NO
Norway
Prior art keywords
substances
administered
polypeptide nature
preparation
hclo4
Prior art date
Application number
NO932101A
Other languages
English (en)
Other versions
NO932101L (no
NO932101D0 (no
Inventor
Alberto Bartorelli
Angela Turiano
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of NO932101D0 publication Critical patent/NO932101D0/no
Publication of NO932101L publication Critical patent/NO932101L/no
Publication of NO308396B1 publication Critical patent/NO308396B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO932101A 1990-12-11 1993-06-09 FremgangsmÕte ved fremstilling av substanser av polypeptidnatur NO308396B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT02234190A IT1244879B (it) 1990-12-11 1990-12-11 Estratti da tessuti animali, utili in terapia e in diagnostica.
PCT/EP1991/002354 WO1992010197A1 (en) 1990-12-11 1991-12-09 Substances of polypeptide nature useful in human therapy

Publications (3)

Publication Number Publication Date
NO932101D0 NO932101D0 (no) 1993-06-09
NO932101L NO932101L (no) 1993-08-10
NO308396B1 true NO308396B1 (no) 2000-09-11

Family

ID=11194931

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932101A NO308396B1 (no) 1990-12-11 1993-06-09 FremgangsmÕte ved fremstilling av substanser av polypeptidnatur

Country Status (16)

Country Link
US (1) US5824640A (no)
EP (1) EP0574394B1 (no)
JP (1) JP3213942B2 (no)
KR (1) KR100196028B1 (no)
AT (1) ATE122890T1 (no)
AU (1) AU661287B2 (no)
CA (1) CA2098113C (no)
CZ (1) CZ283037B6 (no)
DE (1) DE69110060T2 (no)
DK (1) DK0574394T3 (no)
ES (1) ES2073277T3 (no)
HU (1) HU217615B (no)
IT (1) IT1244879B (no)
NO (1) NO308396B1 (no)
RU (1) RU2113224C1 (no)
WO (1) WO1992010197A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27048C2 (uk) * 1993-10-18 2000-02-28 Центр Ембріональних Тканин "Емселл" Лікарський препарат імуhокоригуючої дії hа осhові клітиhhої суспеhзії, спосіб лікуваhhя цукрового діабету з використаhhям цього препарату
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IT1276860B1 (it) * 1994-11-04 1997-11-03 Zetesis Spa Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
IT1276707B1 (it) * 1995-06-13 1997-11-03 Zetesis Spa Composizioni farmaceutiche ad attivita' analgesica
IT1282608B1 (it) * 1996-02-13 1998-03-31 Zetesis Spa Sequenza oligonocleotidica da fegato di capra
IT1284524B1 (it) * 1996-09-13 1998-05-21 Zetesis Spa Uso di proteine come agenti anti-retrovirali
JP2001501925A (ja) 1996-09-18 2001-02-13 ツェテシス・ソシエタ・ペル・アチオニ 自己免疫疾患に対する物質としてのタンパク質の使用
IT1298442B1 (it) * 1998-02-24 2000-01-10 Zetesis Spa Composizioni orali a basso dosaggio di proteine citotossiche
US6855694B2 (en) 2000-06-08 2005-02-15 Rakepoll Holding B.V. Method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
US20030153511A1 (en) * 2000-06-08 2003-08-14 Alberto Panerai Method of treatment of huntington's chorea with a protein extractable from mammalian organs
CA2411430A1 (en) * 2000-06-08 2001-12-13 Rakepoll Holding B.V. A method of treatment of parkinson's disease with a protein extractable from mammalian organs
US20030165492A1 (en) * 2000-06-08 2003-09-04 Alberto Panerai Method of treatment of alzheimer's disease with a protein extractable from mammalian organs
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
ITMI20022307A1 (it) * 2002-10-30 2004-04-30 Zetesis Spa Associazioni anti-tumorali comprendenti proteine e chemioterapici.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598811A (en) * 1977-01-12 1981-09-23 Hoffmann La Roche Carcinoma-associated antigens
EP0149468B1 (de) * 1984-01-12 1990-10-31 SYMBIOTEC Gesellschaft zur Forschung und Entwicklung auf dem Gebiet der Biotechnologie GmbH Biologisch wirksame Substanz mit hormonellen Eigenschaften, Verfahren zu ihrer Herstellung und Verwendung von Histonen für medizinische Zwecke
JPH064675B2 (ja) * 1985-07-29 1994-01-19 伝一 水野 抗腫瘍性ポリペプチド

Also Published As

Publication number Publication date
DE69110060D1 (de) 1995-06-29
JP3213942B2 (ja) 2001-10-02
CZ111693A3 (en) 1994-04-13
US5824640A (en) 1998-10-20
DK0574394T3 (da) 1995-10-16
HU217615B (hu) 2000-03-28
HUT64569A (en) 1994-01-28
RU2113224C1 (ru) 1998-06-20
CA2098113C (en) 2002-02-05
NO932101L (no) 1993-08-10
CA2098113A1 (en) 1992-06-11
CZ283037B6 (cs) 1997-12-17
IT1244879B (it) 1994-09-12
ATE122890T1 (de) 1995-06-15
IT9022341A0 (it) 1990-12-11
IT9022341A1 (it) 1992-06-11
WO1992010197A1 (en) 1992-06-25
KR100196028B1 (ko) 1999-06-15
AU9035791A (en) 1992-07-08
EP0574394A1 (en) 1993-12-22
EP0574394B1 (en) 1995-05-24
DE69110060T2 (de) 1995-09-28
ES2073277T3 (es) 1995-08-01
AU661287B2 (en) 1995-07-20
NO932101D0 (no) 1993-06-09
JPH06504039A (ja) 1994-05-12
HU9301677D0 (en) 1993-09-28

Similar Documents

Publication Publication Date Title
NO308396B1 (no) FremgangsmÕte ved fremstilling av substanser av polypeptidnatur
DE69738754D1 (de) Hemmer der interaktion zwischen p53 und mdm2
HUP0302532A2 (hu) Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások
TW428026B (en) Bifunctional protein, preparation and use
DK0584266T3 (da) Rekombinant virus udtrykkende carcinoembryonalt antigen og fremgangsmåder til anvendelse heraf
BR9808881A (pt) Compostos para imunoterapia de câncer de próstata e métodos para seu uso
RU95110767A (ru) Днк, кодирующая гликопротеин человеческого происхождения
DE69733834D1 (de) Thyroxin-analoge mit keiner signifikanten hormonellen aktivität zur behandlung von bösartigen tumoren
RU95108385A (ru) Пептиды, способ их получения, фармацевтическая композиция и способ ее получения
ATE329030T1 (de) Nukleinsäure, welche einen von lektin abstammenden faktor zur präservierung von progenitorzellen kodiert
NZ309659A (en) Composition comprising LbeIF4A and/or LmeIF4A polypeptides (Leishmania antigen) and methods for enhancing immune responses
IT8148663A0 (it) Linea di cellule derivate da epato ma umano per studi metabolici coltivazione di virus e preparazione di vaccini e procedimento di preparazione
RU93042874A (ru) Соединения полипептидной природы, способ их получения, композиция на их основе, их применение в противоопухолевой терапии
BR9609026A (pt) Composição processo para o tratamento do cáncer e de detecção para a produção de citicina por tumores para determinar a eficácia de um autólogo e kit diagnóstico para detecção para eficácia de compostos celulares autólogos
Shi et al. Proteomic detection of changes in protein synthesis induced by lanthanum in BGC-823 human gastric cancer cells
CA2078773A1 (en) Gp75 as a tumor vaccine for melanoma
AU6987696A (en) The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells
HUP0300923A2 (hu) RAF és RAS protein kinázt tartalmazó készítmények és alkalmazásuk angiogenezis módosítására
Castiglioni et al. First results of tissue culture in Drosophila
EP0136093A3 (en) Anti-cancer factors
SU1077090A1 (ru) Способ получени вещества,специфически св зывающего раково-эмбриональный антиген опухолей толстого кишечника человека
Macher et al. Melanoma: Clinical and Therapeutic Aspects
DE68911305D1 (de) Das lungenwachstum stimulierende und hemmende faktoren für krebstumorzellen.
CA2045593A1 (en) Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans
ATE98262T1 (de) Das lungenwachstum stimulierende und hemmende faktoren fuer krebstumorzellen.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees